Targeting the Genus Leishmania with Small Molecules03/24/2021 - 02/28/2026 (Multi-PI)
PI:
Scott Schaus, PhDNIH/National Institute of Allergy & Infectious Diseases5R01AI151639-04
Advancement of a poxvirus inhibitor03/12/2020 - 02/28/2025 (Co-Investigator)
PI:
John H. Connor, PhDNIH/National Institute of Allergy & Infectious Diseases5R01AI151559-05
Treatment of HCC by Targeting LSF with small Molecules02/10/2020 - 08/01/2021 (Multi-PI)
PI:
Scott Schaus, PhDShepherd Therapeutics
Accelerating General Anesthetic Discovery and Mechanisms Research with Zebrafish08/01/2018 - 07/31/2021 (Co-Investigator)
Massachusetts General Hospital NIH NIGMS5R01GM128989-03
Enantioselective Catalytic Boronate Reactions01/01/2015 - 12/31/2019 (PI)
NIH/National Institute of General Medical Sciences5R01GM078240-09
High-Throughput Chemistry Platform (HTCP) for Reaction Screening01/01/2018 - 03/31/2019 (Co-Investigator)
PI:
Aaron Beeler, PhDDepartment of Defense/DARPA
New Compounds for the Treatment of Leishmaniasis12/30/2013 - 03/01/2017 (PI)
GlaxoSmithKline Investigacion y Desarrollo, S.L.
Treatment of HCC by Targeting LSF with small Molecules01/01/2014 - 12/31/2014 (PI)
PharmLogic, LLC
COMPLEX CHEMOTYPES: DISCOVERY, METHODOLOGY, AND LIBRARY EXPANSION - LSC09/01/2010 - 08/31/2014 (Key Person)
PI:
John A. Porco, PhDNIH/National Institute of General Medical Sciences5P50GM067041-10